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        The IgH constant region (C  H  ) determines the 
class and eff  ector functions of immunoglobu-
lins. IgH class switch recombination (CSR) 
allows activated B cells to switch from pro-
duction of IgM to other Ig classes, including 
IgG, IgE, and IgA. In mice, the exons that en-
code diff  erent IgH classes (termed C  H   genes) 
are organized as 5      –  VDJ  –  C      –  C      –  C    3  –  C    1  –
  C    2b  –  C    2      –  C      –  C      –  3     (  1  ). Each C  H   gene 
that undergoes CSR is preceded by 1  –  10-kb 
repetitive switch (S) region sequences. CSR 
involves introduction of double-strand breaks 
(DSBs) into the donor S     region and into an 
acceptor downstream S region, followed by 
joining of the donor and acceptor S regions and 
replacement of C     with a downstream C  H   
gene (  1  ). CSR requires activation-induced cyti-
dine deaminase (AID) (  2  ), a single-strand DNA 
cytidine deaminase thought to initiate CSR by 
deaminating cytidines in S regions, with result-
ing mismatches ultimately processed by base 
excision and/or mismatch repair pathways to 
generate DSB intermediates (  3  ). After synap-
sis, broken donor and acceptor S regions are 
joined by either classical nonhomologous end-
joining or alternative end-joining pathways (  4  ). 
DSBs generated by the ISceI endonuclease can, 
at least in part, functionally replace S regions 
to mediate recombinational IgH class switch-
ing, suggesting that S regions evolved as opti-
mal AID targets to generate suffi   cient numbers 
of DSBs to promote CSR (  5  ). In this context, 
deletion of S     or S    1, or replacement of S re-
gions with random intronic sequences, greatly 
reduces or abrogates CSR (  6  –  9  ). 
  Mammalian S regions are unusually G rich 
on the coding strand and are primarily com-
posed of tandem repetitive sequences such 
as TGGGG, GGGGT, GGGCT, GAGCT, 
and AGCT, with the distribution of individual 
repetitive sequences varying among diff  erent 
S regions (  1  ). The length of mouse S regions 
varies, with the 10-kb S    1 being the largest. 
Gene-targeted mutation studies in mice have 
shown a positive correlation between S region 
length and the frequency of CSR to individual 
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specifi  c motifs within the endogenous S    3 (  19, 21, 22  ), and 
mutation of these motifs within a synthetic S    3 abolishes 
S region  –  specifi  c CSR, supporting the notion that factor 
binding to these elements directs CSR to S    3 (  21  ). In con-
trast to transient CSR substrate studies, studies of stably inte-
grated transcribed S region substrates suggested that individual 
loci (  9  ), correlating with the fact that IgG1, with the longest 
S region, is the most abundant IgH isotype. Most normal 
CSR junctions occur within and, occasionally, just beyond 
the S regions (  10  ). 
  Individual C  H   genes are organized into transcription units 
with transcription initiating from an intronic (I) promoter lo-
cated upstream of each S region (  11  ). In vivo, CSR is stimu-
lated by T cell  –  dependent and independent antigens, which 
can be mimicked in vitro by activating B cells with anti-
CD40 or bacterial LPS in the presence of cytokines such as 
IL-4 (  1  ). Diff  erent activators and cytokine combinations ap-
pear to infl  uence CSR to particular S regions by modulating 
germline transcription (  11  ). Mechanistically, transcription 
through an S region may target CSR by generating optimal 
DNA substrates for AID. In this context, transcription 
through mammalian S regions, in association with their G-
rich top strand, results in the formation of an R loop struc-
ture (  7, 12, 13  ) that provides single-strand DNA that can 
serve as an AID substrate. However, gene targeting experi-
ments have shown that the   Xenopus   S     region, which is not 
G rich and does not form R loops upon transcription, can 
functionally replace the mouse S    1 region, providing about 
one quarter of its activity compared with a size-matched S    1 
region (  13  ). In this context, biochemical experiments have 
shown that AID can access transcribed substrates that are rich 
in AGCT motifs but that do not form R loops via a mecha-
nism that involves association with replication protein A (  14  ). 
In mice, CSR to   Xenopus   S    , targeted in place of S    1, ap-
pears to primarily involve a region that is rich in AGCT motifs 
(  13  ). Overall, these fi  ndings support the notion that tran-
scription targets specifi  c CSR events by generating AID sub-
strates in S regions through a mechanism that involves 
targeting of AID to regions rich in AGCT motifs, and that 
such access may be further enhanced in mammalian S regions 
via R loop formation (  13  ). 
  Various lines of evidence suggested that CSR to certain 
S regions (S    3, S    1, S    , and S    ) is mediated by S region  –
  specifi  c factors (  15  –  24  ). In particular, plasmid-based switch 
substrates revealed several IgH isotype  –  specifi  c CSR activ-
ities (  18, 20  ). Notably, the recombination on particular 
switch plasmids (e.g.,      to      substrates) occurred only in lines 
that underwent CSR within the same endogenous S regions 
(e.g.,      to      but not      to     3). Comparison of switch sub-
strates specifi  c for      to      and for      to     3 implicated S    3- and 
S    -specifi  c CSR factors (  18  ), and similar studies provided ev-
idence for S    1-specifi  c CSR factors (  20  ) (for review see ref-
erence   24  ). In addition, substrate studies showed that a single 
S    3 or S    1 consensus repeat (49 bp), respectively, supported 
specifi  c      to     3 or      to     1 CSR, suggesting that IgH isotype 
specifi  city of CSR can be mediated by a single repeat unit 
(  21  ). Point mutations of the S    3 consensus repeat showed its 
activity to be dependent on the integrity of an NF-    B bind-
ing site (  21, 22  ). In this regard, B cells defi  cient in the   p50   
subunit of NF-kB under certain conditions produce     3 
germline transcripts but are greatly impaired for switching 
from      to     3 (  15, 19  ). The NF-kB p50 homodimer binds to 
    Figure 1.         Targeting and replacement of the S    1a allele.   (A)  Ge-
nomic organization of S    1 (top) and the design of targeting constructs 
(bottom) are shown. After gene targeting and Cre recombination, the 
neomycin (neo) gene will be deleted. Inverted loxP sites allow for chang-
ing the orientation of different sequences. I    1 and C    1 are depicted as 
black rectangles. H,   HindIII  ; P,   PstI  ; R1,   EcoRI  ; RV,   EcoRV  ; X,   XbaI ;  tri-
angles, loxP sites; +, physiological transcriptional orientation;   	 ,  inverted 
transcriptional orientation. (B) Southern blot analyses of genomic DNA 
digested with HindIII and hybridized with a 3     probe. This probe on F1 ES 
cells detects 20- and 22-kb bands, which represent the endogenous    1 
locus from B6 and 129 alleles, respectively. A crosshybridizing band from 
the    2b/   2a regions is detected with the same probe because of strong 
sequence homology. The middle sample was a mix of two clones (2-
SS    3) and was not used in the experiments. 2-SS    1 has been described 
previously (reference   9  ).     JEM VOL. 205, July 7, 2008  1569
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line transcription of the C    1 gene and CSR to IgG1. Sub-
sequently, we measured the relative levels of steady-state 
germline transcription from the WT     1  b   and targeted     1  a   al-
leles by RT-PCR (  Fig. 2  ) (  5, 9, 13  ).   The level of the endog-
enous     1  b   transcript serves as an internal control, and could 
be distinguished by an   MboI   restriction site polymorphism 
only present in the C57B6 allele. The SS    1, S    3, and SS    3 
replacements generated similar levels of germline transcripts 
to those from the WT     1  b   allele. 
  Transient studies suggested that S    3 has the potential to 
support CSR in B cells stimulated to undergo CSR to S    1 
(  21  ). To compare CSR effi   ciency of S    3- or SS    3-replaced 
endogenous S    1 alleles with S    1 alleles harboring similar 
lengths of S    1 repeats, we performed ELISA to quantify 
IgG1  a   versus total IgG1 in the anti-CD40 plus IL-4 culture 
supernatants (  5, 7, 9, 13  ). The WT controls were splenic B 
cells derived from WT F1 ES cells using RAG2-defi  cient 
blastocyst complementation. The ratio of IgG1  a   to total IgG1 
in WT F1 cells was set at 100% (  7  ). These experiments 
showed that in anti-CD40 plus IL-4  –  stimulated B cells, size-
matched sequences of SS    1, S    3, or SS    3 all generated levels 
of IgG1  a   secretion that ranged from 25  –  50% of those of WT 
primary S region sequences may not play a critical role in di-
recting CSR (  25  ). 
  To generate a physiologically relevant mouse model to 
test for S region specifi  city of CSR, we measured the activity 
of WT or synthetic S    3 sequences inserted in place of the 
endogenous S    1. We fi  nd that sized-matched S    3, synthetic 
S    3, and synthetic S    1 all mediate endogenous CSR, sug-
gesting that the particular sequence of the S region is not a 
predominant factor in targeting endogenous CSR to IgG1. 
    RESULTS AND DISCUSSION   
  We used our previously established strategy to replace the 
endogenous 10-kb S    1  a   region of a     1  a  /    1  b   F1 embryonic 
stem (ES) cell line with a 2-kb portion of endogenous S    3 
(2-S    3), a 2-kb synthetic S    3 (2-SS    3), and a 2-kb syn-
thetic S    1 (2-SS    1;   Fig. 1  ) (  7, 9, 13  ).   For generation of the 
2-SS    3 sequence, we used linkers to concatemerize 40 copies 
(    2 kb) of the S    3 consensus sequence (Fig. S1, available at 
http://www.jem.org/cgi/content/full/jem.20080451/DC1). 
The orientation of tandem repeats in the SS    3 is unidirec-
tional, therefore mimicking the repeat structure and nucleo-
tide content of the endogenous S   3 ( 26  ). The 2-S   3 sequence 
comprises 1946 bp of the endogenous S    3 region from 
nucleotides 646 to 2592 (available from GenBank/EMBL/
DDBJ under accession no.   M12182  ) (  26  ). This sequence has 
been previously shown to mediate recombination in tran-
sient assays and has been used to assay for S region  –  specifi  c 
factors (  18, 20  ). The WT S    1 repeat is nearly identical to 
the synthetic S    1 region and functionally supports CSR in 
a linear fashion compared with the WT S    1 sequence (  9  ). 
The purpose of testing synthetic S    1 and S    3 substrates was 
to determine if this approach would allow endogenous CSR 
assays of substrates in which the only variables were the few 
nucleotide diff  erences within each repeat unit and also to be 
able to test potential functions of candidate motifs within a 
given S region by generation of synthetic sequences with dif-
fering repeat structures. 
  The F1 ES cell was derived from the hybrid 129Sv-
C57BL/6 mice in which the two   IgH   alleles represent the 
  IgH  a     (from 129/Sv) or   IgH  b     (from C57BL/6) allotypes, re-
spectively. The presence of sequence polymorphisms and al-
lotypic markers (antibodies to IgG1  a  ) facilitates comparison 
of the level of CSR on modifi  ed alleles to the internal con-
trol of the unmodifi  ed   IgH  b     allele. After successful gene tar-
geting, the inserted   neo   cassette was removed by   loxP/Cre   
recombination (  Fig. 1  ). To analyze the eff  ect of transcription 
orientation, the two   loxP   sites fl  anking the insert were placed 
in inverted orientation, allowing Cre-mediated recombina-
tion to invert the test sequences. Southern blot analyses were 
performed to confi  rm the correct integration of the replaced 
sequences (  Fig. 1 B  ) (  9  ). The S    1-replaced mutant F1 ES 
cells were injected into RAG2-defi  cient blastocysts to gener-
ate chimeric mice to obtain mature B lymphocytes harboring 
the targeted mutation (  27  ). Splenocytes from mutant and 
control mice were activated for 2 d with antibody against 
CD40 (anti-CD40) plus IL-4, a treatment that induces germ-
    Figure 2.         Germline transcripts from the S    1 replacement alleles.   
Germline transcripts were RT-PCR amplifi  ed via the I    1 and C   1  primers 
and subsequently subjected to primer extension. The fi  nal products were 
digested with   MboI   restriction enzyme to distinguish between C57B6 and 
129 alleles. Representative data from a minimum of two experiments are 
shown. The black line indicates that intervening lanes have been spliced out.     
    Figure 3.         ELISA on anti-CD40/IL-4  –  stimulated splenocytes.   The 
ratio of IgG1  a  /IgG1 total of the WT-S    1 mice is set as 100% for the IgG1  a  
allele. Data from WT and 2-SS    1 were adopted from a previous study 
(reference   9  ). Physiological (+) and inverted (  	  ) orientations of each se-
quence were obtained by Cre/loxP. Error bars represent the standard de-
viation of the mean (triangles).     1570 S    3 FUNCTIONS IN PLACE OF S    1 TO MEDIATE CSR   | Zarrin et al. 
inserted S region sequence clearly resulted in substantially 
decreased IgH class switching to IgG1  a   (  Fig. 3   and   Table I  ), 
potentially caused by decreased R loop formation in the 
inverse direction (  7, 9, 13  ). Finally, we used a nested PCR 
approach to map S     to SS    3 junctions in IgG1  a  -producing 
hybridomas. Junctions occurred throughout the SS    3 repeat, 
similar to WT S    3 (Fig. S3, available at http://www.jem.org/
cgi/content/full/jem.20080451/DC1) (  10  ). Although four out 
of eight junctions (50%) fell into a GAGCT motif surrounded 
by G nucleotides, further mutational studies on synthetic S re-
gions would be required to identify the motifs that are prefer-
entially targeted during CSR in vivo. 
  Given the central role of IgH isotype class switching in the 
humoral immunity, it is of signifi  cant interest to identify the 
mechanisms that contribute to the specifi  city of this process. 
Past studies have led to the view that S region  –  specifi  c factors 
may be required for targeting CSR to S    3 versus S    1, and 
vice versa (  24  ). In this report, we show that synthetic or WT 
S    3, or size-matched S    1 sequences, when inserted in place 
of the endogenous S    1, can mediate roughly similar levels of 
CSR under B cell activation conditions in which CSR to the 
endogenous S    1, but not the endogenous S    3, is induced. 
We have previously shown that the   Xenopus   S     sequence, 
when substituted for the mouse S    1 region, can mediate CSR 
at substantial levels, even though it is AT rich and lacks the 
ability to form an R loop structure in vitro (  13  ) and in vivo 
(Leiber, M., personal communication). Thus, our previous 
  Xenopus   S     replacement study (  13  ) complements our current 
fi  ndings; collectively, these studies strongly indicate that nu-
cleotide sequence diff  erences between S    1 and other S re-
gions are not likely to be major determinants of endogenous 
IgG1 CSR targeting. Correspondingly, our current fi  ndings 
support germline transcriptional activation of the S    1 region 
as the primary mechanism for targeting CSR to IgG1 (  28, 
29  ). In this context, the fi  nding that S    3 sequences in place of 
S    1 sequences do not support CSR to IgG1 under conditions 
(LPS activation) in which IgG3 CSR is induced would refl  ect 
the fact that LPS fails to induce germline transcription of the 
C    1 gene promoter. Finally, we note that our approach now 
can be used to test for potential roles of putative S region  –  spe-
cifi  c factors in mediating specifi  c CSR events to other S re-
gions under other stimulation conditions (  21, 24  ). 
  MATERIALS AND METHODS 
  Targeting constructs.     To generate synthetic S    3, the consensus S    3 
(5      -GGATCC  GGGGAGCTGGGGTAGGTTGGGAGTGTGGGGACCA-
GGCTGGGCAGCTCTG  AGATCT  -3    ; BamHI and BglII sites are under-
lined; reference   26  ) was oligomerized by sequential cloning into the BamHI 
site of S85 vector to generate 2-SS    3 (Fig. S1). After each cloning step, the 
insert orientation was confi  rmed by sequencing and restriction endonucle-
ase digestion. The consensus repeats were confi  rmed to be unidirectional. 
The 2-SS    3 sequence was excised as a NotI and SalI fragment and cloned 
into the targeting construct previously described (  9  ). The endogenous S    3 
region was excised as a BamHI/NotI fragment from pSV5 plasmid (pro-
vided by A. Kenter, University of Illinois at Chicago, Chicago, IL) and 
cloned into pBluescript. Subsequently, the NotI/SalI fragment was ligated 
into the targeting vector as previously described (  9  ). 2-SS    1 has been previ-
ously described (  9  ). 
alleles (  Fig. 3  ).   On the other hand, stimulation of 2-S    3 sple-
nocytes for up to 6 d by treatment with LPS, conditions that 
normally induce germline C    3 gene transcription and IgG3 
CSR, did not result in any signifi  cant increase in IgG1 pro-
duction in either WT or mutant B cells (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20080451/DC1), 
consistent with the fact that the germline     1 gene is not tran-
scribed under LPS stimulation conditions. 
  To quantify CSR at a single-cell level, we generated 
hybridomas from activated B cells. Hybridomas represent 
fusions of individual B cells to the myeloma partner cell 
line. We selected IgG1-producing hybridomas by ELISA 
and compared the level of IgG1  a   with IgG1  b   to score for 
recombination effi     ciency between WT and mutated al-
leles. The IgH locus is subject to allelic exclusion, and only 
one of the two IgH alleles in a given B cell is recombined 
functionally into a V(D)J coding region. Therefore, in an 
F1 control, half of the activated B cells should produce 
IgH  a   allotype antibodies, and the other half should pro-
duce IgH  b   allotype antibodies. Relative CSR frequency is 
defi  ned by the ratio of IgG1  a  - to IgG1  b  - producing hy-
bridomas (IgG1  a  /IgG1  b  ) and is arbitrarily set as 100% for 
the F1 control. In these experiments, the WT F1 B cell 
population stimulated with anti-CD40/IL-4 yielded 63 
IgG1  a  - and 42 IgG1  b  -producing hybridomas (  Table I  ).   In 
the absence of S    1, we did not fi  nd any IgG1  a  -producing 
hybridomas (0 IgG1  a   and 160 IgG1  b   hybridomas), as ex-
pected (  7  ). Compared with the control, the relative ratio 
of IgG1  a  /IgG1  b   hybridomas was 31% in 2-SS    1, 30% 
in 2-SS    3, and 47% in 2-S    3, respectively. Therefore, the 
levels of CSR to alleles in which S    1 sequences were re-
placed with endogenous or synthetic S    3 sequences was at 
least as high as those to alleles in which S    1 was replaced 
with synthetic S    1. 
  Although the levels of CSR supported by the 2-S    3 re-
placement alleles appeared slightly higher in both the ELISA 
and hybridoma analyses, the diff  erences in the ELISA analyses 
were not statistically signifi  cant. Determining whether or not 
there is a slight preference for the 2-S    3 sequences would 
require further study. However, inversion of each type of 
    Table I.        Ratio of IgG1  a /IgG1 b   in hybridomas 
Genotype IgG1  a  /IgG1  b CSR  (%)
WT-S    1 63:42 100
  Δ  S    1 0:160 0
2-SS    1  +  38:81 31
2-SS    1    	   16:112 9
2-SS    3  +  43:94 30
2-SS    3    	   12:96 8
2-S    3  +  52:72 47
2-S    3    	   6:30 13
The numbers of IgG1  a   or  IgG1 b   are indicated. Relative CSR frequency is defi  ned by 
the ratio of IgG1  a  - to IgG1  b  -producing hybridomas and is arbitrarily set as 100% for 
F1 cells (see Materials and methods). The data for WT and 2-SS    1 were adopted 
from our previous study (reference   9  ).JEM VOL. 205, July 7, 2008  1571
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  Gene targeting, generation of RAG chimeras, and mutant B cells.   
  The targeting constructs were transfected into ES cells in which the S    1  a   
was deleted (  7  ). The targeted ES cells were identifi  ed by Southern blotting 
as described in   Fig. 1 B   (  13  ). The deletion of the   neo  r     gene was achieved by 
infecting ES cells with cre-expressing adenovirus. Targeted ES cells were 
subcloned and injected into RAG2-defi  cient blastocysts to produce mature 
lymphocytes that all harbored the mutant allele (  27  ). Splenic B cells from 
6  –  8-wk-old chimeras were used in our experiments. Mouse protocols 
were approved by the Institutional Animal Care and Use Committee of 
Children  ’  s Hospital. 
  Isotype switching assays.     ELISA and hybridoma analysis were performed 
as previously described (  13  ). Spleen cells from 6  –  8-wk-old chimeras were 
stimulated in vitro with 1   μ  g/ml anti-CD40 (HM40-3; BD Biosciences) plus 
25 ng/ml IL-4, or 20   μ  g/ml LPS alone. 1.5   ×   10  6   cells were seeded in one 
well of a sixwell plate (0.5   ×   10  6   cells/ml) in RPMI 1640 media supple-
mented with 10% FBS, 2 mM glutamine, 100 U/ml penicillin  –  streptomy-
cin, and 100   μ  M   
  -mercaptoethanol. Stimulated B cells were used to 
generate hybridomas (after 4 d) or ELISA (after 6 d), as previously described 
(  7, 13  ). Monoclonal anti  –  mouse IgG1  a   (Igh-4a; BD Biosciences) was used to 
detect IgG1  a   (from the mutated allele). Alkaline phosphotase  –  conjugated 
goat anti  –  mouse IgG1 (SouthernBiotech) was used as the detection anti-
body. Purifi  ed mouse IgG1  a   (BD Biosciences) was used as the standard. 
Because an antibody specifi  c for IgG1  b   is not available, we normalized the 
production of IgG1  a   against IgG1 total for ELISA assays on splenic B cell 
stimulations. The ratio of IgG1  a  /IgG1 total of the WT F1 chimeras was de-
fi  ned as 100% CSR effi   ciency for the WT     1a allele. We measured the ratio 
of IgG1  a   to IgG1 for diff  erent chimeras. Relative CSR effi   ciency was calcu-
lated by the ratio of IgG1  a  - to IgG1  b  -producing hybridomas. Hybridomas 
that produced only IgG1 and not IgG1  a   were considered to produce IgG1  b  . 
We defi  ned the numbers of cells that switched     1 on the a or b allele as     1a 
and     1b, respectively, and the numbers of total Ig  +   cells for the two alleles as 
Ig  a   and Ig  b  , respectively. The switching effi   ciency to     1 was given as Sa = 
Sa/Sb = (    1a/    1b)/(Ig  b  /Ig  a  ). The ratio of Ig  a  /Ig  b   was determined by the 
relative ratio of productive V(D)J recombination on the two alleles and was 
expected to be close to 1. Thus, Ra can be simplifi  ed as     1  a  /    1  b  . After muta-
tion of S    1, Ra     =     1a    /    1b    , and Ra    /Ra = (    1a    /    1b    )/    1  a  /    1  b  ) (  7  ). For 
example, 2-SS    1 produced 38 IgG1  a  -producing and 81 IgG1  b  -producing 
hybridomas. We normalized this ratio by dividing (38/81) to (63/42 = 1.5) 
to determine the CSR frequency of the mutated allele (31%). 
  CSR junctions.     CSR junctions were amplifi  ed from hybridomas by nested 
PCR (  13  ). Nested mouse I     primers were 5    -CTCTGGCCCTGCT-
TATTGTTG-3     followed by 5    -AGACCTGGGAATGTATGGTT-3      .   
The reverse nested primers were located in exon1 of C    1, and were 
5    -CAATTTTCTTGTCCACCTTGGTGCTG-3     followed by 5    -GTG-
TGCACACCGCTGGACAGG-3    . PCR products were gel purifi  ed and 
sequenced. S junctions were analyzed with the SeqMan program (DNAStar 
Lasergene) and the MEGABLAST program (National Center for Biotech-
nology Information; Fig. S3). 
  Online supplemental material.     Fig. S1 shows the nucleotide alignment 
of the synthetic S    3 and endogenous S    3. Fig. S2 shows ELISA of LPS-
stimulated splenocytes from 2-S    3. Fig. S3 provides an analysis of CSR 
junctions. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20080451/DC1. 
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